A prospective epidemiological study of new incident GISTs during two consecutive years in Rh??ne Alpes region: incidence and molecular distribution of GIST in a European region, British Journal of Cancer, vol.25, issue.2, pp.165-70, 2010. ,
DOI : 10.1002/cncr.20862
Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study, European Journal of Cancer, vol.41, issue.18, pp.41-2868, 2005. ,
DOI : 10.1016/j.ejca.2005.09.009
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations, Proceedings of the National Academy of Sciences, vol.108, issue.1, pp.314-322, 2011. ,
DOI : 10.1073/pnas.1009199108
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST, European Journal of Human Genetics, vol.34, issue.1, pp.32-41, 2014. ,
DOI : 10.1097/PAS.0b013e3182613c86
Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors, Clinical Cancer Research, vol.14, issue.10, pp.3204-3219, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-1984
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours, Journal of Clinical Pathology, vol.62, issue.7, pp.62-613, 2009. ,
DOI : 10.1136/jcp.2009.064550
Mutation Status in Gastrointestinal Stromal Tumors, American Journal of Clinical Pathology, vol.133, issue.1, pp.141-149, 2010. ,
DOI : 10.1309/AJCPPCKGA2QGBJ1R
Gastrointestinal stromal tumor and other primary metachronous or synchronous neoplasms as a suspicion criterion for syndromic setting, Oncology Reports, vol.23, issue.2, pp.437-481, 2010. ,
DOI : 10.3892/or_00000653
A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.456, issue.1-2, pp.39-44, 2000. ,
DOI : 10.1016/S0027-5107(00)00112-3
Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma, Cancer, vol.6, issue.10, pp.98-2245, 2003. ,
DOI : 10.1002/cncr.11778
Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants, PLoS ONE, vol.23, issue.4, p.62119, 2013. ,
DOI : 10.1371/journal.pone.0062119.s003
Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations, Clin Sarcoma Res, vol.3, issue.1, p.12, 2013. ,
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis, British Journal of Cancer, vol.103, issue.4, pp.482-487, 2010. ,
DOI : 10.1093/jnci/djj417
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT, BMC Cancer Br J Dermatol, issue.5, pp.159-1160, 2008. ,
Identification of kit<sup>M541L</sup> somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response, Oncotarget, vol.5, issue.13, pp.4665-70, 2014. ,
DOI : 10.18632/oncotarget.1941
KIT Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors, Clinical Cancer Research, vol.14, issue.8, pp.14-2285, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4102
URL : https://hal.archives-ouvertes.fr/hal-00283136
To answer rare cancer issues. Geographical analysis of EMS sarcoma cohort in the Rhône-Alpes region] 2014 Feb, Bull Cancer, vol.101, issue.2, pp.127-163 ,
Recent advances in the understanding of mastocytosis: the role of KIT mutations, British Journal of Haematology, vol.30, issue.1, pp.12-30, 2007. ,
DOI : 10.1073/pnas.97.14.7732
Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia ??? potential clinical significance, Leukemia, vol.16, issue.2, pp.170-177, 2002. ,
DOI : 10.1038/sj.leu.2402341
The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population, Journal of Clinical Pathology, vol.64, issue.11, pp.64-1021, 2011. ,
DOI : 10.1136/jcp.2011.090498
Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics, PLoS ONE, vol.26, issue.11, p.7746, 2009. ,
DOI : 10.1371/journal.pone.0007746.t005
The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians, Leukemia, vol.12, issue.2, pp.354-359, 2006. ,
DOI : 10.1038/sj.leu.2404038